Over the last 5 years studies on the genetic foundations of BPDCN revealed a peculiar genotype with a complex karyotype and recurrent deletions in several tumor suppressor genes, such as RB1, TP53, CDKN2A and CDKN2B [19, 20,21, 28]. This evidence concerns the gene CDKN2A and neoplasm.